Particularly, gelatinases MMP2 and MMP9 appear highly expressed in breast cancer tissues and are strongly associated with tumor staging and metastasis, particularly driving TNBC metastasis, thereby serving as important biomarkers for assessing prognosis and guiding treatment strategies [58,59]. This evidence concerns the gene MMP9 and neoplasm.